Kevin Brosseau is seeking to stem the flow of a deadly opioid not only to reverse U.S. tariffs but to end domestic drug deaths.
Study represents the first clinical application of CMND-100, the Company’s proprietary drug platform Vancouver, Canada, March 18, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: ...
New guidelines around involuntary care are receiving criticism from those who advocate for drug users and their families ...
This milestone marks a significant step forward in Rakovina’s mission to accelerate drug discovery using advanced AI-driven platforms. In September 2024, Rakovina announced its partnership with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results